查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1573948

勝任細胞市場：按應用、電池類型、最終用戶、產品供應、技術 - 全球預測 2025-2030

Competent Cells Market by Application (Biotechnology, Clinical Research, Industrial), Cell Type (E. coli Competent Cells, Mammalian Competent Cells, Other Bacterial Competent Cells), End User, Product Offerings, Technology - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年勝任細胞市場價值為20.1億美元，預計到2024年將達到22.1億美元，複合年成長率為8.76%，到2030年將達到36.2億美元。

勝任細胞在分子生物學中對於轉化過程中吸收外源DNA至關重要，並且在生物技術研究、基因工程和藥物開發中發揮重要作用。這些細胞經過化學或電處理以增加膜對 DNA 的滲透性。勝任細胞的需求涵蓋克隆技術、蛋白質表現和基因修飾等領域的應用，使其成為專注於基因工程和合成生物學的實驗室的基本工具。最終用途範圍涵蓋學術研究機構、製藥公司和生物技術公司，這些細胞對於基因克隆和藥物製造等關鍵業務至關重要。

主要市場統計
基準年[2023] 20.1億美元
預計年份 [2024] 22.1億美元
預測年份 [2030] 36.2億美元
複合年成長率（%） 8.76%

根據市場洞察，勝任細胞市場的成長是由合成生物學的進步、重組技術資金的增加以及生物製藥需求的增加所推動的。基因工程的不斷創新正在增加對勝任細胞的需求並推動市場擴張。 CRISPR 技術的進步和下一代療法的開發帶來了商機，為有興趣的相關人員創造了潛在的夥伴關係和投資途徑。為了抓住新的成長機會，建議專注於市場擴張，特別是在亞太地區，因為生物技術領域的快速成長和政府的積極舉措。

相反，存在一些可能抑制市場滲透的限制因素，例如與生產相關的高成本以及有關基因操縱的道德問題。監管障礙和嚴格的核准流程帶來了額外的挑戰。創新和研究可以集中在提高 DNA 攝取效率、開發具有成本效益的高效菌株以及改進冷凍保存技術以維持細胞活力。透過簡化生產流程和投資自動化平台來最佳化製造和可擴展性。市場的本質是高度動態的，其特點是技術快速進步以及現有和新興參與企業爭奪市場佔有率的競爭格局。透過將技術創新與行業需求結合並解決監管挑戰，公司可以實現永續成長和競爭優勢。

市場動態：揭示快速發展的勝任細胞市場的關鍵市場洞察

勝任細胞市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 擴大勝任細胞在基因治療和個人化醫療的應用
    • 慢性疾病盛行率上升，需要使用勝任細胞進行高階研究
    • 開發具有更高轉化效率的新勝任細胞系
    • 研究機構和生物技術公司之間加強合作以改善細胞技術
  • 市場限制因素
    • 一些勝任細胞系的轉化效率有限，限制了它們在複雜遺傳實驗中的使用
    • 與生產和儲存相關的高成本阻礙了它們在小規模研究和學術研究中的應用。
  • 市場機會
    • 提高工業規模生物技術過程中勝任細胞的效率與產量
    • 利用高性能勝任細胞拓展農業生物技術的市場潛力
    • 勝任細胞在環境生物技術污染防治與生物修復的應用
  • 市場問題
    • 使用勝任細胞產生的基因改造生物 (GMO) 的核准和商業化的監管障礙
    • 關於感受勝任細胞技術促進的基因改造的倫理問題和公眾認知問題

波特五力：駕馭勝任細胞市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解勝任細胞市場的外部影響

外部宏觀環境因素在塑造勝任細胞市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解感受勝任細胞市場的競爭狀況

對勝任細胞市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位勝任細胞市場供應商的績效評估

FPNV定位矩陣是評估勝任細胞市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了勝任細胞市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，勝任細胞市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 勝任細胞在基因治療和個人化醫療的應用不斷增加
      • 慢性疾病的增加需要使用勝任細胞進行高階研究
      • 開發具有更高轉化效率的新感受態細胞株
      • 擴大研究機構與生物技術公司之間的合作以改善細胞技術
    • 抑制因素
      • 一些感受態細胞株的有限轉化效率限制了它們在複雜遺傳實驗中的使用
      • 感受勝任細胞生產和儲存的高成本阻礙了小規模和學術研究應用
    • 機會
      • 提高工業規模生物技術過程中勝任細胞的效率與產量
      • 拓展高性能農業生物技術勝任細胞的市場潛力
      • 勝任細胞在環境生物技術中污染控制和生物修復的應用
    • 任務
      • 使用勝任細胞產生的基因改造生物 (GMO) 的核准和商業化的監管障礙
      • 使用勝任細胞技術進行基因改造的倫理問題和公眾意識問題
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章勝任細胞市場：依應用分類

  • 介紹
  • 生物技術
    • 基因工程
    • 蛋白質表現
  • 臨床研究
    • 診斷
    • 治療開發
  • 產業
    • 生物轉化
    • 發酵
  • 製藥
    • 藥物發現
    • 疫苗開發
  • 研究與開發
    • 生物資訊學
    • 微生物學
    • 分子生物學

第7章勝任細胞市場：依細胞類型

  • 介紹
  • 大腸桿菌勝任細胞
    • 化學感受態大腸桿菌
    • 電感受態大腸桿菌
  • 哺乳動物勝任細胞
    • CHO細胞
    • HEK細胞
  • 其他細菌勝任細胞
    • 枯草桿菌
    • 乳酸乳球菌
  • 酵母勝任細胞
    • P. pastoris
    • S. cerevisiae

第8章勝任細胞市場：依最終用戶分類

  • 介紹
  • 學術研究所
    • 非營利研究中心
    • 大學
  • 農業研究所
  • 生技公司
    • 成熟的生物技術
    • Start-Ups生技公司
  • 合約研究組織
  • 製藥公司

第9章勝任細胞市場：依產品分類

  • 介紹
  • 勝任細胞套件
    • 化學轉換套件
    • 電穿孔試劑套件
  • 試劑及耗材
    • 抗生素
    • 生長培養基
    • 質體
  • 服務
    • 自訂克隆服務
    • 自訂蛋白表達服務

第10章勝任細胞市場：依技術分類

  • 介紹
  • 化學轉化
  • 電穿孔

第11章美洲的勝任細胞市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太勝任細胞市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲的勝任細胞市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議
Product Code: MRR-1A1A064C00F0

The Competent Cells Market was valued at USD 2.01 billion in 2023, expected to reach USD 2.21 billion in 2024, and is projected to grow at a CAGR of 8.76%, to USD 3.62 billion by 2030.

Competent cells are essential in molecular biology for the uptake of foreign DNA during the transformation process, with a significant scope in biotechnology research, genetic engineering, and pharmaceutical development. These cells are chemically or electrically treated to increase membrane permeability to DNA. The necessity of competent cells spans their application in cloning techniques, protein expression, and genetic modification, serving as fundamental tools for laboratories focused on genetic engineering and synthetic biology. The end-use scope covers academic research institutions, pharmaceutical companies, and biotechnology firms, with these cells critical for crucial operations like gene cloning and pharmaceutical production.

KEY MARKET STATISTICS
Base Year [2023] USD 2.01 billion
Estimated Year [2024] USD 2.21 billion
Forecast Year [2030] USD 3.62 billion
CAGR (%) 8.76%

Market insights reveal the growth of the competent cells market driven by advances in synthetic biology, increased funding for recombinant technology, and rising demand for biopharmaceuticals. Continued innovation in genetic engineering amplifies the demand for competent cells, propelling market expansion. Opportunities arise from advancements in CRISPR technologies and next-generation therapeutic development, creating potential partnerships and investment avenues for stakeholders. Emphasizing regional market expansion, particularly in Asia-Pacific due to burgeoning biotech sectors and favorable government initiatives, is recommended to capture emerging growth opportunities.

Conversely, limitations include high costs associated with production and ethical concerns regarding genetic manipulation that could stymie market advancement. Regulatory hurdles and stringent approval processes present further challenges. Innovation and research can focus on enhancing the efficiency of DNA uptake, developing cost-effective and higher competency strains, and improving cryopreservation techniques for preserving cell viability. Streamlining production processes and investing in automated platforms can optimize manufacturing and scalability. The nature of the market is highly dynamic, characterized by rapid technological advancements and a competitive landscape filled with established and emerging players vying for market share. By aligning technological innovations with industry demands and addressing regulatory challenges, companies can achieve sustained growth and competitive advantage.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Competent Cells Market

The Competent Cells Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • increased application of competent cells in gene therapy and personalized medicine
    • rising prevalence of chronic diseases necessitating advanced research using competent cells
    • development of new competent cell strains with enhanced transformation efficiency
    • growing collaborations between research institutions and biotechnology companies to improve cell technologies
  • Market Restraints
    • Limited efficiency in transformation of some competent cell strains imposing constraints on usage in complex genetic experiments
    • High costs associated with production and storage of competent cells hindering small-scale and academic research applications
  • Market Opportunities
    • Enhancing the efficiency and yield of competent cells for industrial-scale biotechnology processes
    • Market potential in expanding agricultural biotechnology with high-performance competent cells
    • Applications of competent cells in environmental biotechnology for pollution control and bio-remediation
  • Market Challenges
    • Regulatory hurdles in approval and commercialization of genetically modified organisms (GMOs) created using competent cells
    • Ethical concerns and public perception issues regarding genetic modifications facilitated by competent cell technologies

Porter's Five Forces: A Strategic Tool for Navigating the Competent Cells Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Competent Cells Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Competent Cells Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Competent Cells Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Competent Cells Market

A detailed market share analysis in the Competent Cells Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Competent Cells Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Competent Cells Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Competent Cells Market

A strategic analysis of the Competent Cells Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Competent Cells Market, highlighting leading vendors and their innovative profiles. These include Addgene, Agilent Technologies, Bio-Rad Laboratories, BioDynamics Laboratory, Bioneer Corporation, Cayman Chemical Company, Cell Applications, Edge BioSystems, GenScript Biotech, Lucigen Corporation, Merck Group, New England Biolabs, OriGene Technologies, Promega Corporation, QIAGEN, Scarab Genomics, Takara Bio, Thermo Fisher Scientific, Yeastern Biotech, and Zymo Research.

Market Segmentation & Coverage

This research report categorizes the Competent Cells Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Application, market is studied across Biotechnology, Clinical Research, Industrial, Pharmaceutical, and Research and Development. The Biotechnology is further studied across Genetic Engineering and Protein Expression. The Clinical Research is further studied across Diagnostics and Therapeutic Development. The Industrial is further studied across Bioconversion and Fermentation. The Pharmaceutical is further studied across Drug Discovery and Vaccine Development. The Research and Development is further studied across Bioinformatics, Microbiology, and Molecular Biology.
  • Based on Cell Type, market is studied across E. coli Competent Cells, Mammalian Competent Cells, Other Bacterial Competent Cells, and Yeast Competent Cells. The E. coli Competent Cells is further studied across Chemically Competent E. coli and Electrocompetent E. coli. The Mammalian Competent Cells is further studied across CHO Cells and HEK Cells. The Other Bacterial Competent Cells is further studied across B. subtilis and L. lactis. The Yeast Competent Cells is further studied across P. pastoris and S. cerevisiae.
  • Based on End User, market is studied across Academic and Research Institutes, Agricultural Research Organizations, Biotech Companies, Contract Research Organizations, and Pharmaceutical Companies. The Academic and Research Institutes is further studied across Non-profit Research Centers and Universities. The Biotech Companies is further studied across Established Biotechs and Startup Biotechs.
  • Based on Product Offerings, market is studied across Competent Cell Kits, Reagents and Consumables, and Services. The Competent Cell Kits is further studied across Chemical Transformation Kits and Electroporation Kits. The Reagents and Consumables is further studied across Antibiotics, Growth Media, and Plasmids. The Services is further studied across Custom Cloning Services and Custom Protein Expression Services.
  • Based on Technology, market is studied across Chemical Transformation and Electroporation.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. increased application of competent cells in gene therapy and personalized medicine
      • 5.1.1.2. rising prevalence of chronic diseases necessitating advanced research using competent cells
      • 5.1.1.3. development of new competent cell strains with enhanced transformation efficiency
      • 5.1.1.4. growing collaborations between research institutions and biotechnology companies to improve cell technologies
    • 5.1.2. Restraints
      • 5.1.2.1. Limited efficiency in transformation of some competent cell strains imposing constraints on usage in complex genetic experiments
      • 5.1.2.2. High costs associated with production and storage of competent cells hindering small-scale and academic research applications
    • 5.1.3. Opportunities
      • 5.1.3.1. Enhancing the efficiency and yield of competent cells for industrial-scale biotechnology processes
      • 5.1.3.2. Market potential in expanding agricultural biotechnology with high-performance competent cells
      • 5.1.3.3. Applications of competent cells in environmental biotechnology for pollution control and bio-remediation
    • 5.1.4. Challenges
      • 5.1.4.1. Regulatory hurdles in approval and commercialization of genetically modified organisms (GMOs) created using competent cells
      • 5.1.4.2. Ethical concerns and public perception issues regarding genetic modifications facilitated by competent cell technologies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Competent Cells Market, by Application

  • 6.1. Introduction
  • 6.2. Biotechnology
    • 6.2.1. Genetic Engineering
    • 6.2.2. Protein Expression
  • 6.3. Clinical Research
    • 6.3.1. Diagnostics
    • 6.3.2. Therapeutic Development
  • 6.4. Industrial
    • 6.4.1. Bioconversion
    • 6.4.2. Fermentation
  • 6.5. Pharmaceutical
    • 6.5.1. Drug Discovery
    • 6.5.2. Vaccine Development
  • 6.6. Research and Development
    • 6.6.1. Bioinformatics
    • 6.6.2. Microbiology
    • 6.6.3. Molecular Biology

7. Competent Cells Market, by Cell Type

  • 7.1. Introduction
  • 7.2. E. coli Competent Cells
    • 7.2.1. Chemically Competent E. coli
    • 7.2.2. Electrocompetent E. coli
  • 7.3. Mammalian Competent Cells
    • 7.3.1. CHO Cells
    • 7.3.2. HEK Cells
  • 7.4. Other Bacterial Competent Cells
    • 7.4.1. B. subtilis
    • 7.4.2. L. lactis
  • 7.5. Yeast Competent Cells
    • 7.5.1. P. pastoris
    • 7.5.2. S. cerevisiae

8. Competent Cells Market, by End User

  • 8.1. Introduction
  • 8.2. Academic and Research Institutes
    • 8.2.1. Non-profit Research Centers
    • 8.2.2. Universities
  • 8.3. Agricultural Research Organizations
  • 8.4. Biotech Companies
    • 8.4.1. Established Biotechs
    • 8.4.2. Startup Biotechs
  • 8.5. Contract Research Organizations
  • 8.6. Pharmaceutical Companies

9. Competent Cells Market, by Product Offerings

  • 9.1. Introduction
  • 9.2. Competent Cell Kits
    • 9.2.1. Chemical Transformation Kits
    • 9.2.2. Electroporation Kits
  • 9.3. Reagents and Consumables
    • 9.3.1. Antibiotics
    • 9.3.2. Growth Media
    • 9.3.3. Plasmids
  • 9.4. Services
    • 9.4.1. Custom Cloning Services
    • 9.4.2. Custom Protein Expression Services

10. Competent Cells Market, by Technology

  • 10.1. Introduction
  • 10.2. Chemical Transformation
  • 10.3. Electroporation

11. Americas Competent Cells Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Competent Cells Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Competent Cells Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Addgene
  • 2. Agilent Technologies
  • 3. Bio-Rad Laboratories
  • 4. BioDynamics Laboratory
  • 5. Bioneer Corporation
  • 6. Cayman Chemical Company
  • 7. Cell Applications
  • 8. Edge BioSystems
  • 9. GenScript Biotech
  • 10. Lucigen Corporation
  • 11. Merck Group
  • 12. New England Biolabs
  • 13. OriGene Technologies
  • 14. Promega Corporation
  • 15. QIAGEN
  • 16. Scarab Genomics
  • 17. Takara Bio
  • 18. Thermo Fisher Scientific
  • 19. Yeastern Biotech
  • 20. Zymo Research

LIST OF FIGURES

  • FIGURE 1. COMPETENT CELLS MARKET RESEARCH PROCESS
  • FIGURE 2. COMPETENT CELLS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COMPETENT CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COMPETENT CELLS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COMPETENT CELLS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COMPETENT CELLS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES COMPETENT CELLS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES COMPETENT CELLS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. COMPETENT CELLS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. COMPETENT CELLS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COMPETENT CELLS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COMPETENT CELLS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COMPETENT CELLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COMPETENT CELLS MARKET DYNAMICS
  • TABLE 7. GLOBAL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COMPETENT CELLS MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COMPETENT CELLS MARKET SIZE, BY PROTEIN EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COMPETENT CELLS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COMPETENT CELLS MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOCONVERSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COMPETENT CELLS MARKET SIZE, BY FERMENTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL COMPETENT CELLS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL COMPETENT CELLS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOINFORMATICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL COMPETENT CELLS MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL COMPETENT CELLS MARKET SIZE, BY MOLECULAR BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHEMICALLY COMPETENT E. COLI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL COMPETENT CELLS MARKET SIZE, BY ELECTROCOMPETENT E. COLI, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL COMPETENT CELLS MARKET SIZE, BY HEK CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL COMPETENT CELLS MARKET SIZE, BY B. SUBTILIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL COMPETENT CELLS MARKET SIZE, BY L. LACTIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL COMPETENT CELLS MARKET SIZE, BY P. PASTORIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL COMPETENT CELLS MARKET SIZE, BY S. CEREVISIAE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL COMPETENT CELLS MARKET SIZE, BY NON-PROFIT RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL COMPETENT CELLS MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL COMPETENT CELLS MARKET SIZE, BY AGRICULTURAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL COMPETENT CELLS MARKET SIZE, BY ESTABLISHED BIOTECHS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL COMPETENT CELLS MARKET SIZE, BY STARTUP BIOTECHS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL COMPETENT CELLS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHEMICAL TRANSFORMATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL COMPETENT CELLS MARKET SIZE, BY ELECTROPORATION KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL COMPETENT CELLS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL COMPETENT CELLS MARKET SIZE, BY GROWTH MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL COMPETENT CELLS MARKET SIZE, BY PLASMIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL COMPETENT CELLS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL COMPETENT CELLS MARKET SIZE, BY CUSTOM CLONING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL COMPETENT CELLS MARKET SIZE, BY CUSTOM PROTEIN EXPRESSION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL COMPETENT CELLS MARKET SIZE, BY CHEMICAL TRANSFORMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL COMPETENT CELLS MARKET SIZE, BY ELECTROPORATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 86. AMERICAS COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. AMERICAS COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 88. AMERICAS COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 89. AMERICAS COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 90. AMERICAS COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 91. AMERICAS COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 92. AMERICAS COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. AMERICAS COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. AMERICAS COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 100. ARGENTINA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 101. ARGENTINA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ARGENTINA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 103. ARGENTINA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 104. ARGENTINA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 105. ARGENTINA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 106. ARGENTINA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 107. ARGENTINA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 108. ARGENTINA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 109. ARGENTINA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 110. ARGENTINA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 111. ARGENTINA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 112. ARGENTINA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 113. ARGENTINA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. BRAZIL COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. BRAZIL COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 117. BRAZIL COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 118. BRAZIL COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 119. BRAZIL COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 120. BRAZIL COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. BRAZIL COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 122. BRAZIL COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 123. BRAZIL COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 124. BRAZIL COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 125. BRAZIL COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. BRAZIL COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 127. BRAZIL COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 128. BRAZIL COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 129. BRAZIL COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 130. BRAZIL COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 131. BRAZIL COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 132. BRAZIL COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. CANADA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. CANADA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 135. CANADA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 136. CANADA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 137. CANADA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 138. CANADA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 139. CANADA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. CANADA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 141. CANADA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 142. CANADA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 143. CANADA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 144. CANADA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. CANADA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 146. CANADA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 147. CANADA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 148. CANADA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 149. CANADA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 150. CANADA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 151. CANADA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. MEXICO COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. MEXICO COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. MEXICO COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 155. MEXICO COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 156. MEXICO COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 157. MEXICO COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 158. MEXICO COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. MEXICO COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 160. MEXICO COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 161. MEXICO COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 162. MEXICO COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 163. MEXICO COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 164. MEXICO COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 165. MEXICO COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 166. MEXICO COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 167. MEXICO COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 168. MEXICO COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 169. MEXICO COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. MEXICO COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 171. UNITED STATES COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. UNITED STATES COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. UNITED STATES COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 174. UNITED STATES COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 175. UNITED STATES COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 176. UNITED STATES COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 177. UNITED STATES COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED STATES COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED STATES COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED STATES COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED STATES COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED STATES COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED STATES COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED STATES COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED STATES COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED STATES COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED STATES COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED STATES COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED STATES COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED STATES COMPETENT CELLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC COMPETENT CELLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 211. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 213. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 214. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 215. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 216. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 217. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 219. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 220. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 221. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 222. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 224. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 225. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 226. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 227. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 228. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 229. AUSTRALIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. CHINA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. CHINA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. CHINA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 233. CHINA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 234. CHINA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 235. CHINA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 236. CHINA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. CHINA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 238. CHINA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 239. CHINA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 240. CHINA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 241. CHINA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 242. CHINA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 243. CHINA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 244. CHINA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 245. CHINA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 246. CHINA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 247. CHINA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 248. CHINA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. INDIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. INDIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. INDIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 252. INDIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 253. INDIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 254. INDIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. INDIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. INDIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 257. INDIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 258. INDIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 259. INDIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 260. INDIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 261. INDIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 262. INDIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 263. INDIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 264. INDIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 265. INDIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 266. INDIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 267. INDIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 268. INDONESIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. INDONESIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 270. INDONESIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 271. INDONESIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 272. INDONESIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 273. INDONESIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 274. INDONESIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. INDONESIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 276. INDONESIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 277. INDONESIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 278. INDONESIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 279. INDONESIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 280. INDONESIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 281. INDONESIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 282. INDONESIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 283. INDONESIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 284. INDONESIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 285. INDONESIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 286. INDONESIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 287. JAPAN COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 288. JAPAN COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 289. JAPAN COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 290. JAPAN COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 291. JAPAN COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 292. JAPAN COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 293. JAPAN COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 294. JAPAN COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 295. JAPAN COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 296. JAPAN COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 297. JAPAN COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 298. JAPAN COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 299. JAPAN COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 300. JAPAN COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 301. JAPAN COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 302. JAPAN COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 303. JAPAN COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 304. JAPAN COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 305. JAPAN COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 306. MALAYSIA COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 307. MALAYSIA COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 308. MALAYSIA COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 309. MALAYSIA COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 310. MALAYSIA COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 311. MALAYSIA COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 312. MALAYSIA COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 313. MALAYSIA COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 314. MALAYSIA COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 315. MALAYSIA COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 316. MALAYSIA COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 317. MALAYSIA COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 318. MALAYSIA COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 319. MALAYSIA COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 320. MALAYSIA COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 321. MALAYSIA COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 322. MALAYSIA COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 323. MALAYSIA COMPETENT CELLS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 324. MALAYSIA COMPETENT CELLS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 325. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 326. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY BIOTECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 327. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY CLINICAL RESEARCH, 2018-2030 (USD MILLION)
  • TABLE 328. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY INDUSTRIAL, 2018-2030 (USD MILLION)
  • TABLE 329. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY PHARMACEUTICAL, 2018-2030 (USD MILLION)
  • TABLE 330. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 331. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 332. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY E. COLI COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 333. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY MAMMALIAN COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 334. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY OTHER BACTERIAL COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 335. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY YEAST COMPETENT CELLS, 2018-2030 (USD MILLION)
  • TABLE 336. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 337. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 338. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY BIOTECH COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 339. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY PRODUCT OFFERINGS, 2018-2030 (USD MILLION)
  • TABLE 340. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY COMPETENT CELL KITS, 2018-2030 (USD MILLION)
  • TABLE 341. PHILIPPINES COMPETENT CELLS MARKET SIZE, BY REAGENTS AND CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 342. PHILIPPINES COMPETENT CELLS MARKE